Autopsy report · NCT04214015

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

“Company focus shifted”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

ProgenaBiome

Sponsor type

University, hospital or other

Conditions

Mesothelioma; Mesothelioma Malignant; Mesothelioma; Lung; Mesotheliomas Pleural; Mesothelioma Peritoneum; Mesothelioma; Liver

Interventions

No intervention

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Pilot Study to Explore the Role of Gut Flora in Gout
  “Company shifted focus” (98% match in meaning)
• POMCO2 Clinical Study MicroTrend System pCO2 Sensor
  “Change in focus by the company.” (82% match in meaning)
• Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft vs Standard of Care in Participants With Dry Eye Disease
  “Change in company strategy.” (62% match in meaning)
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
  “company focus on other projects” (60% match in meaning)
• The Effects of Injection Site Cooling and Solution Buffering on Perceived Pain During Local Anesthesia Administration
  “Shift in research focus” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.